| Pseudomonas aeruginosa (NORTHCENTRAL Data) | |||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
| ceftazidime | 86.8% n=491 | 87.1% n=279 | 87.7% n=130 | 84.3% n=191 | 93.8% n=306 | 91.6% n=502 | |
| cefepime | 88.8% n=143 | 85.7% n=161 | 87.1% n=93 | 92.9% n=70 | 88.7% n=71 | ||
| ciprofloxacin | 74.1% n=491 | 84.9% n=279 | 79.1% n=258 | 79.5% n=224 | 85.6% n=236 | 71.5% n=431 | |
| levofloxacin | 74.4% n=379 | 85.7% n=279 | 80.2% n=258 | 76.3% n=317 | 82.7% n=306 | 67.7% n=502 | |
| gentamicin | 79.4% n=491 | 92.5% n=279 | 86.9% n=130 | 83.3% n=317 | 95.1% n=306 | 91.8% n=502 | |
| tobramycin | 94.3% n=491 | 95.7% n=279 | 96.2% n=130 | 94% n=317 | 99% n=306 | 99% n=502 | |
| amikacin | 98.7% n=379 | 96.9% n=161 | 93.5% n=93 | 98.6% n=70 | 97.2% n=71 | ||
| aztreonam | 78.4% n=379 | 75.2% n=161 | 85% n=60 | 78% n=41 | 80.8% n=52 | ||
| meropenem | 100% n=119 | 89.1% n=119 | |||||
| imipenem | 87.4% n=491 | 90.7% n=279 | 93.1% n=130 | 90.5% n=317 | 95.1% n=306 | 100% n=71 | |
| piperacillin | 87.8% n=255 | 87.8% n=279 | 96.9% n=130 | 91.8% n=98 | 95.8% n=236 | 97.1% n=312 | |
| pip/taz | 92.9% n=491 | 91% n=279 | 97.7% n=130 | 96.5% n=317 | 98.4% n=306 | 95.8% n=502 | |
| Totals | 85.5% n=4481 | 88.8% n=2715 | 87.7% n=1296 | 87.2% n=2344 | 93.5% n=2608 | 88% n=3637 | |
This data is accurate as of: 11/22/2016 11:53:50 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: cefepime, amikacin, aztreonam, piperacillin, imipenem.
